ICDS (ICDSLTD)

Score breakdown: P/E: 1/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Piotroski F-Score of 7/9 indicates decent recent financial health across operations, margins, and efficiency.
• ROCE of 11.85% is above ROE of 6.89%, suggesting the underlying capital employed is generating a reasonable pre-tax return.
• Promoter holding of 51.39% aligns management's interests with minority shareholders.
• Book value of ₹19.97 provides a tangible base, though current price is well above it.

Concerns

• Zero sales growth and zero profit growth, with latest quarter sales of just ₹1 crore and net profit of ₹0 crore.
• P/E of 22.69 and P/B of 2.25 look expensive for a business earning only 6.89% ROE.
• No dividend yield, so shareholders receive no cash return while waiting for uncertain growth.
• Tiny ₹54 crore market cap and illiquid 52-week range of ₹36.40-₹62.32 increase risk and volatility.

AI Analysis

At ₹44.90, this is a ₹54 crore microcap with a vague 'diversified commercial services' label. My first test is always: what durable advantage does this company have? I don't see it. Price-to-book of 2.25 times ₹19.97 book value demands high returns on equity, yet ICDS earns only 6.89%. For a business with zero sales and profit growth, a P/E of 22.69 is far from a bargain. The latest quarter tells a worrying story: sales of just ₹1 crore and net profit of ₹0 crore. The company pays no dividend, so the small shareholder gets no cash while waiting for results. On the positive side, the Piotroski F-score of 7/9 suggests recent financial health, ROCE of 11.85% at least exceeds its apparent capital cost, and promoters hold 51.39%, aligning owners and management. The 52-week range of ₹36.40 to ₹62.32 shows a volatile, low-liquidity stock, not a steady compounder. The PEG ratio of 0.26 looks tempting, but with reported profit growth of 0.00%, I'd distrust that number as possible market optimism or a thin-base anomaly. In Graham's language, the margin of safety is missing. I need years of consistent earnings, a clearer business model, and proof of pricing power before investing. At this price, I'm not a buyer; I'd wait for either a better price near the lower end of book value or evidence that earnings can grow materially from this tiny base. This is, at best, a slow grower to watch, not a bet to make.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer